2. Academic Validation
  3. GPR84 regulates pulmonary inflammation by modulating neutrophil functions

GPR84 regulates pulmonary inflammation by modulating neutrophil functions

  • Acta Pharmacol Sin. 2023 Apr 4;1-11. doi: 10.1038/s41401-023-01080-z.
Si-Wei Wang # 1 2,  Qing Zhang # 1 3 4,  Dan Lu 5,  You-Chen Fang 1,  Xiao-Ci Yan 1 2 3,  Jing Chen 1 2,  Zhi-Kan Xia 1 2,  Qian-Ting Yuan 1,  Lin-Hai Chen 1,  Yang-Ming Zhang 6,  Fa-Jun Nan 1 3 4,  Xin Xie 7 8 9 10 11
Affiliations

Affiliations

  • 1 State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • 2 University of Chinese Academy of Sciences, Beijing, 100049, China.
  • 3 School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China.
  • 4 Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264117, China.
  • 5 School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • 6 Burgeon Therapeutics Co., Ltd., Shanghai, 201203, China.
  • 7 State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. xxie@simm.ac.cn.
  • 8 University of Chinese Academy of Sciences, Beijing, 100049, China. xxie@simm.ac.cn.
  • 9 School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China. xxie@simm.ac.cn.
  • 10 Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264117, China. xxie@simm.ac.cn.
  • 11 School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China. xxie@simm.ac.cn.
  • # Contributed equally.
PMID: 37016043 DOI: 10.1038/s41401-023-01080-z
Abstract

Acute lung injury (ALI) is an acute, progressive hypoxic respiratory failure that could develop into acute respiratory distress syndrome (ARDS) with very high mortality rate. ALI is believed to be caused by uncontrolled inflammation, and multiple types of immune cells, especially neutrophils, are critically involved in the development of ALI. The treatment for ALI/ARDS is very limited, a better understanding of the pathogenesis and new therapies are urgently needed. Here we discover that GPR84, a medium chain fatty acid receptor, plays critical roles in ALI development by regulating neutrophil functions. GPR84 is highly upregulated in the cells isolated from the bronchoalveolar lavage fluid of LPS-induced ALI mice. GPR84 deficiency or blockage significantly ameliorated ALI mice lung inflammation by reducing neutrophils infiltration and oxidative stress. Further studies reveal that activation of GPR84 strongly induced Reactive Oxygen Species production from neutrophils by stimulating Lyn, Akt and ERK1/2 activation and the assembly of the NADPH Oxidase. These results reveal an important role of GPR84 in neutrophil functions and lung inflammation and strongly suggest that GPR84 is a potential drug target for ALI.

Keywords

GPR84; ROS; acute lung injury; antagonist; inflammation; neutrophil.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z